Credo Technology is upgraded from Watchlist to Buy. The investment score rises from 66 to 70. The August report on this company named two conditions, either of which would trigger the upgrade: a share price below $210, and a September quarter guided above $520m. Both have now happened, and they happened in opposite directions.

The bull case. Fiscal first-quarter revenue of $479.0m beat both the $471.8m consensus and the company’s own $465m-$475m guidance range, the fifth consecutive quarter in which reported revenue has landed above the guided top end. Non-GAAP earnings of $1.20 beat the $1.17 the street carried. Gross margin held at 68% and non-GAAP net income of $236.3m was a record, a 49.3% net margin. More importantly, the September quarter was guided to $525m-$535m against an LSEG consensus of $515.8m, and the full-year outlook was reframed from more than 80% revenue growth to more than 85%, with the $600m-plus optical target reaffirmed and broken into three lines each guided above $100m. The first half has come in some $45m ahead of the path modelled in August, which lowers the sequential step the January quarter must deliver from roughly 34% to roughly 30%.

The bear case. Customer concentration got worse, not better. The top four customers were 33%, 28%, 13% and 10% of the quarter, so 84% of revenue sits with four buyers and 61% with two. Operating cash flow fell $92m sequentially as inventory rose $62.2m ahead of the second-half ramp, cutting free cash flow conversion to 35% of non-GAAP net income. Cash fell $679m to $764.3m on the DustPhotonics acquisition, halving a balance-sheet cushion that was previously close to unimprovable. The guidance is also explicitly conditioned on a tariff regime management themselves described as fluid. And the chart is broken: the shares sit below every computable moving average, with the 100-day average having risen through the price rather than supporting it, and the MACD has crossed down.

The decisive change is in what is being paid. The probability-weighted fair value of $225 sat 5% below the market price in August. It now sits 9% above the last close of $206.63, and roughly 17% above the middle of the recommended $185-$200 buy range. The forward multiple has compressed from 40.6x to 33.5x while the company raised its own guidance, largely because a Fabrinet read-across and a Middle East risk-off session did the work.

Entry levels, the cut-loss and the full scenario analysis are set out in the complete Credo Technology (CRDO) report on our Reports page.